NCH Launches EEG Diagnostic Services, Expanding Neurophysiology Access

Nashik Civil Hospital (NCH) has launched dedicated EEG diagnostic services, a step that gives patients local access to routine electroencephalography — the recording of the brain's electrical activity through scalp electrodes — without referral to a private facility. The Times of India reported the launch, though the report did not specify the number of machines installed, the recording capacity per day, or the staffing model behind the new service.

What has actually been announced?

The announcement concerns one concrete development: EEG diagnostic services now exist at NCH. The source does not state whether the offering covers routine awake scalp EEG alone, or extends to sleep-deprived studies, prolonged monitoring, or video-EEG telemetry — the combination of continuous EEG with synchronized camera recording used in epilepsy evaluation.

Readers in clinical neurophysiology will want the specifics that the report omits:

• The type of instrument (a standard 21-channel international 10–20 system montage versus a higher-density acquisition system)
• Whether studies are read on-site by a neurologist or transmitted elsewhere for interpretation
• Patient volume targets, waiting times, and referral criteria
• Cost to patients, if any, given the public-hospital setting

None of these parameters appears in the source material, and EEG Signal will update this story as the institution releases them.

Why a public-hospital EEG service matters

Access to EEG remains uneven in many regions, and the gap concentrates in public healthcare. When a government hospital adds EEG capability, the practical effect is usually threefold: shorter travel distances for patients with suspected epilepsy, faster workups after a first unprovoked seizure, and reduced out-of-pocket spending on private diagnostics.

For the reading room and the monitoring unit, a new public EEG service also shifts referral patterns. Neurologists who previously sent patients to private labs can order studies in-house, which matters most for follow-up recordings — repeating an EEG after medication changes or after a first seizure often clarifies whether epileptiform discharges (abnormal electrical spikes indicating a predisposition to seizures) persist.

The scale of that effect at NCH cannot yet be quantified, because the launch report provides no baseline referral volume, no equipment count, and no daily study capacity.

What we do not know yet

The announcement leaves open the question of clinical scope. EEG supports several distinct use cases, and each demands different resources:

• Epilepsy diagnosis and classification — routine 20-to-40-minute scalp recordings, the core application
• Encephalopathy and status epilepticus evaluation — often requiring longer or continuous bedside recordings in intensive care
• Sleep studies — which pair EEG with polysomnography channels and additional technologist training

Whether NCH's service covers only the first category, or all three, will determine its clinical weight. The Times of India report does not say, and this article will not extrapolate beyond what the announcement established.

There is also the question of quality assurance. Accredited EEG laboratories follow standardized technical protocols and reporting conventions; a newly launched service typically needs months before its rejection rates, artifact burden, and report turnaround stabilize. No accreditation status was mentioned in the source.

The road ahead

For now, the verifiable news is narrow but real: scalp EEG diagnostics have arrived at NCH, and patients in its catchment area no longer need to look elsewhere for the study. The next meaningful milestones will be concrete — published study volumes, named interpreting physicians, and, if the service grows, the addition of video-EEG monitoring for presurgical epilepsy workup.